Authors: | Tremblay, C. L.; Poulin, D. L.; Hicks, J. L.; Selliah, S.; Chamberland, A.; Giguel, F.; Kollmann, C. S.; Chou, T. C.; Dong, H.; Hirsch, M. S. |
Article Title: | Favorable interactions between enfuvirtide and 1-β-D-2, 6-diaminopurine dioxolane in vitro |
Abstract: | We evaluated the in vitro anti-human immunodeficiency virus type 1 (HIV-1) interactions between 1-β-D-2,6-diaminopurine dioxolane (DAPD) and enfuvirtide (T-20) against clinical isolates sensitive and resistant to reverse transcriptase and protease inhibitors. Interactions between T-20 and DAPD were synergistic to nearly additive, with combination index values ranging from 0.53 to 1.06 at 95% inhibitory concentrations. These studies suggest that a combination of T-20 and DAPD might be useful in the treatment of antiretroviral drug-experienced patients. |
Keywords: | unclassified drug; human cell; drug activity; drug potentiation; drug synergism; peptide fragments; drug sensitivity; proteinase inhibitor; anti-hiv agents; hiv infections; human immunodeficiency virus 1; drug resistance, viral; hiv-1; virus isolation; rna directed dna polymerase inhibitor; anti human immunodeficiency virus agent; hiv protease inhibitors; purine nucleosides; enfuvirtide; reverse transcriptase inhibitors; humans; human; priority journal; article; 1beta dextro 2,6 diaminopurine dioxolane; 2,6 diaminopurine derivative; dioxolanes; hiv envelope protein gp41 |
Journal Title: | Antimicrobial Agents and Chemotherapy |
Volume: | 47 |
Issue: | 11 |
ISSN: | 0066-4804 |
Publisher: | American Society for Microbiology |
Date Published: | 2003-11-01 |
Start Page: | 3644 |
End Page: | 3646 |
Language: | English |
DOI: | 10.1128/aac.47.11.3644-3646.2003 |
PUBMED: | 14576137 |
PROVIDER: | scopus |
PMCID: | PMC253786 |
DOI/URL: | |
Notes: | Export Date: 12 September 2014 -- Source: Scopus |